ArticleViruses2023

Application of a SARS-CoV-2 Antigen Rapid Immunoassay Based on Active Microfluidic Technology in a Setting of Children and Young Adults.

Christian Leli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.